Nunzia Pharmaceutical Stock Price, News & Analysis
Company Description
Nunzia Pharmaceutical (OTC Link: NUNZ) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.3M.
NUNZ stock has gained 0.0% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of NUNZ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nunzia Pharmaceutical (NUNZ) stock last traded at $0.0001. At a market capitalization of $1.3M, NUNZ is classified as a micro-cap stock with approximately 434.5M shares outstanding.
Latest News
Nunzia Pharmaceutical has 2 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. View all NUNZ news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NUNZ Company Profile & Sector Positioning
Nunzia Pharmaceutical (NUNZ) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NUNZ often look at related companies in the same sector, including Panacea Life Sciences Hldgs Inc (PLSH), Acura Pharm (ACUR), Cbd Life Science (CBDL), Genix Pharmaceut (GENPF), and Allied (ALID). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NUNZ's relative position within its industry.